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Introduction {#sec1}
============

Ubiquitin (Ub) is a small 76-amino-acid protein that functions as a post-translational modifier on a wide range of substrate proteins in the eukaryotic cell ([@bib14]). The process of ubiquitination is initiated by E1, which uses Mg^2+^-ATP to activate Ub and conjugate it to an E2 Ub-conjugating enzyme via a thioester bond between the C-terminal diglycine on Ub and a catalytic cysteine on the E2. Ub from this E2∼Ub complex (∼ denotes the thioester bond) is then transferred to a substrate in a reaction mediated by an E3 ligase, thereby forming an isopeptide bond between the C-terminal glycine of Ub and a free amine group from a substrate lysine or N-terminal methionine ([@bib18], [@bib24]). E3 ligases are divided into three families depending on the Ub transfer mechanism ([@bib4])---HECT, RING, and RING between RING---and of these three, RING E3s are the most abundant ([@bib6]). Ub also associates with many proteins via non-covalent interactions, and a wide range of proteins have Ub-associated domains and Ub-binding domains to facilitate this type of interaction ([@bib7]).

Because Ub uses a common surface to interact with a wide variety of proteins with relatively low affinity, it is an attractive scaffold for engineering variants with greater specificity for select targets ([@bib9], [@bib20]). Previously, we generated a ubiquitin variant (UbV) library ([@bib9]) and used phage display to select UbVs that target and modulate the activities of multiple classes of proteins including deubiquitinases (DUBs), HECT E3 and RING E3 ligases, and Ub-interacting motifs ([@bib3], [@bib11], [@bib13], [@bib23], [@bib34], [@bib32], [@bib33]). Using this method, we unexpectedly identified a dimeric UbV that is selective for the RING domain of XIAP (hereafter referred to as XR) ([@bib11]). In crystal structures of this UbV alone and bound to XR, β1 and β1′ from the two UbV chains are swapped, forming an elongated strand that fulfills all hydrogen-bonding criteria required to complete the β-sheet criteria ([Figure 1](#fig1){ref-type="fig"}A) that occur between β1 and β2 in wild-type Ub. When purified by size-exclusion chromatography, this XR-selective UbV, herein termed UbV.XR, was present in two populations: one corresponding to the molecular weight of a dimer and the other corresponding to that of a monomer. Over time, there was a shift in the population from monomeric to dimeric UbV.XR, and the dimer population was eliminated by reverting Ala10 in UbV.XR to Gly, the corresponding residue in wild-type Ub.Figure 1Substitution of Gly10 to Ala or Val in Ub74 Promotes Dimerization(A) Crystal structure of XIAP RING (gray) and dimeric UbV.XR (green and blue) (PDB: [5O6T](pdb:5O6T){#intref0155}).(B) Sequence alignments of ubiquitin (Ub), UbV.XR, and UbV.pCBL ([@bib11]) with NEDD8-Ubl and SUMO2-Ubl created with ALINE ([@bib2]). Numbering is based on ubiquitin, and identical residues are highlighted in black. Residue 10 is highlighted in red.(C) Normalized analytical size-exclusion chromatograms of Ub74 and variants with substitutions of Gly to Ala or Val in position 10. The profiles of Ub74 G10A and G10V have peaks that elute at volumes consistent with a dimer. See also [Figure S1](#mmc1){ref-type="supplementary-material"}A.(D) Normalized analytical size-exclusion chromatograms of Ub74 G10L immediately following purification and after incubation at 4°C for 14 days. There is no shift from monomer to dimer. See also [Figures S1](#mmc1){ref-type="supplementary-material"}B and S1C.(E) Stability of Ub74 Gly10 variants as measured in a thermofluorescence assay. The monomeric fractions of Ub74 G10A and G10V have lower melting points than Ub74, Ub74 G10F, and Ub74 G10M. Assays were performed in triplicate, and melting points and standard error were calculated using a Boltzmann sigmoid fit in GraphPad Prism. The curves shown are from one set of assays.

In addition to position 10, Ub and UbV.XR differ at a number of other positions in β1 and the loop between β1 and β2, which could influence dimerization. In this work, we have determined the minimum substitutions required to convert wild-type Ub from a stable monomer to a dimer by introducing point mutations in β1 and the loop between β1 and β2. This not only provides a fundamental understanding of Ub protein characteristics, but will allow us to design dimeric libraries of UbVs to expand our target space for developing selective modulators of cellular activity for Ub-binding proteins.

Results {#sec2}
=======

Substitution of Gly10 Is Sufficient to Promote Oligomerization {#sec2.1}
--------------------------------------------------------------

Of the many structures of UbVs in complex with their binding partners determined to date, only UbV.XR has been reported to exist as a dimer. Sequence and structural comparisons of Ub with the UbVs that have been crystallized suggest that substitution of Gly10 might be sufficient to promote Ub dimerization ([Figure 1](#fig1){ref-type="fig"}B). In UbV.XR, Ala10 was shown to be crucial for dimerization. When this residue was reverted to Gly, the variant remained monomeric even when left at 4°C for a week whereas the UbV.XR Ala10 monomer population shifted toward dimer in the same time frame ([@bib11]). However, in UbV.XR, there are a number of additional amino acid substitutions in this region that have not been excluded from having a role in UbV.XR dimerization. To determine whether a single substitution of residue Gly10 in Ub promotes oligomerization, we introduced Gly10 substitutions of increasing size into a construct of Ub lacking the C-terminal diglycine motif (Ub74). Using gel-filtration chromatography, we assessed whether substituting Gly10 in Ub74 with Ala, Val, Leu, Met, Phe, or Arg promoted dimer formation ([Figures 1](#fig1){ref-type="fig"}C and [S1](#mmc1){ref-type="supplementary-material"}A) and found that the Ala and Val substitutions existed in two populations that eluted at volumes consistent with the molecular weights of a Ub monomer and dimer. When left at 4°C for a week, a fraction of the monomer at ∼10 mg/mL slowly converted to a mix of monomeric and dimeric Ub, whereas when left for a week, a fraction of the dimer at ∼10 mg/mL did not revert to monomer ([Figures S1](#mmc1){ref-type="supplementary-material"}B and S1C). When Gly10 was substituted with residues with larger side chains, little evidence of dimer formation was observed, even after a 2-week incubation at 4°C as shown for Ub74 G10L ([Figure 1](#fig1){ref-type="fig"}D). We also measured melting temperatures of Ub74 and the position-10 variants using dynamic fluorescence scanning to assess stability. While Ub74 and Ub74 G10M had melting temperatures of 85.5°C ± 0.2°C and 86.3°C ± 0.2°C, respectively, the monomeric fractions of variants with Ala and Val substitutions had melting temperatures of 79.9°C ± 0.7°C and 81.9°C ± 0.2°C, respectively, showing that these two variants are less stable ([Figure 1](#fig1){ref-type="fig"}E). However, the Ub74 G10F substituted sample had a melting temperature of 84.3°C ± 0.3°C yet remained monomeric. These data show that factors other than mutation-induced instability may contribute to non-covalent dimer formation by Ub.

Ub74 and Ub74 G10V Have Distinct Shapes in Solution {#sec2.2}
---------------------------------------------------

To confirm observations from our gel-filtration analyses, we analyzed Ub74 and the dimer fraction of Ub74 G10V using small-angle X-ray scattering (SAXS). The intensity and Kratky plots are dramatically different for the two samples ([Figures 2](#fig2){ref-type="fig"}A and 2B), suggesting that a single substitution of Gly10 to Val drastically alters the size and shape of Ub. The radius of gyration (*R*~g~) and maximum distance (*D*~max~) were 14.4 Å and 44 Å for Ub74 and 23.9 Å and 76 Å for Ub74 G10V ([Figures 2](#fig2){ref-type="fig"}C and 2D), respectively; these clearly show that Ub74 G10V forms a larger complex in solution than Ub74. The *D*~max~ and *R*~g~ of Ub74 G10V appear to be concentration independent, suggesting that the dimeric state does not change with protein concentration within our tested range (6.25--50 mg/mL). Additionally, when we calculated *ab initio* models of Ub74 G10V and Ub74 based on the experimental data collected, the calculated bead models were distinctly different ([Figures 2](#fig2){ref-type="fig"}E and 2F), and when high-resolution structures of Ub are superposed on the envelopes, the Ub74 G10V envelope accommodates two molecules of Ub and the Ub74 envelope one. Together these data show that Ub74 and Ub74 G10V adopt different conformations in solution consistent in size with a monomer and dimer, respectively.Figure 2Ub74 G10V and Ub74 Adopt Different Conformations(A) Scaled experimental intensity plots of Ub74 (blue) and Ub74 G10V (red) show a clear difference in the conformations of the two samples in solution. The colors representing each sample are consistent throughout the figure.(B) Guinier plot of Ub74 and Ub74 G10V with residuals shown below. *R*~g~ values of 14.4 Å and 23.9 Å were derived from these data for Ub74 and Ub74 G10V, respectively.(C) Kratky plots of Ub74 and Ub74 G10V, highlighting the fundamental differences between the two proteins in solution.(D) Relative pair distribution function (P(r)) of Ub74 with a *D*~max~ of 44 Å and Ub74 G10V with a *D*~max~ of 76 Å.(E) *Ab initio* reconstruction of Ub74 superposed on the crystal structure of Ub from PDB: [1UBQ](pdb:1UBQ){#intref0160}.(F) *Ab initio* reconstruction of Ub74 G10V superposed on the crystal structure from this study.(G) Crystal structure of Ub74 G10V dimer, showing how β1 has exchanged position with β1′ from the partnering subunit. Note that the overall Ub fold is maintained for both chains.(H) Close-up of G10V and the β1β2 loop with Polder map contoured at 2σ.(I) Solution scattering of Ub74 G10V, fitted with the theoretical scattering curve of the crystal structure of Ub74 G10V.

Molecular Structure of Ub74 G10V {#sec2.3}
--------------------------------

To investigate whether Ub74 G10V resembled the UbV.XR dimer, we determined the structure to a resolution of 2.23 Å from crystals grown from the dimeric gel-filtration fractions. There are 12 chains in the asymmetric unit forming six dimers, in which the β1 strands from both subunits of the dimer are swapped and complete the β sheet in the partnering subunit ([Figure 2](#fig2){ref-type="fig"}G and [Table 1](#tbl1){ref-type="table"}) as observed in UbV.XR.Table 1Data Collection and Refinement StatisticsUb74 G10V**Data Collection**PDB ID[6QK9](pdb:6QK9){#intref0175}Space group*P*2~1~2~1~2~1~Cell dimensions *a*, *b*, *c* (Å)83.93, 87.26, 109.84 α, β, γ (°)90, 90, 90Resolution (Å)29.16--2.23 (2.29--2.23)[a](#tblfn1){ref-type="table-fn"}*R*~merge~ (%)9.3 (76.4)*R*~pim~ (%)5.8 (48.5)Completeness (%)99.4 (93.1)Multiplicity6.6 (6.1)*I*/σ*I*13.2 (2.0)CC~1/2~0.98 (0.85)Wilson *B* (Å^2^)34.7**Refinement***R*~work~ (%)23.90*R*~free~ (%)28.1No. of atoms Protein13,886 Water204RMSD bond0.010RMSD angle1.321*B* factors Main chain40.4 Side chain49.9Ramachandran favorable (%)99.65Additional allowed (%)0.35[^4]

Polder maps ([@bib21]) ([Figure 2](#fig2){ref-type="fig"}H) confirm that the electron density for the β1β2 loop clearly extends between two adjacent chains such that β1 interacts with β2′ on a neighboring chain to form a β sheet. Additionally, there are no significant differences between the *B* factors of the atoms involved in the β1 exchange and the remainder of the atoms in each molecule of the dimer. The quality of chains D and H (part of dimers CD and GH, respectively) is poorer than that of the others, reflected by the higher average *B* factors of these chains (72 and 62 Å, respectively) when compared with the overall average *B* factor of all chains (51 Å). The complementary chains in each dimer pair have a complete elongated β1 strand.

Comparison of the crystal structure and solution studies of Ub74 G10V suggests that the dimer from the crystal structure is also present in solution. A theoretical scattering curve calculated from the crystal structure fits well to the solution data with a χ^2^ value of 3.8 compared with the crystal structure of Ub74, which fits with a χ^2^ of 20.8 ([Figure 2](#fig2){ref-type="fig"}I), and the crystal structure of the Ub74 G10V dimer was easily superposed with the envelope calculated from the solution scattering data ([Figure 2](#fig2){ref-type="fig"}F). In addition, the calculated *R*~g~ of the Ub74 G10V crystal structure is 21.5 Å (CRYSOL), fitting closely with the experimentally obtained *R*~g~. In comparison, the calculated *R*~g~ of monomeric Ub from a crystal structure of Ub (1UBQ) and experimentally determined *R*~g~ from Ub74 are 13.6 and 14.0 Å, respectively. These data suggest that the Ub74 G10V dimer is not merely a crystallographic artifact.

The dimer interface comprises around 1,800 Å^2^ of an overall accessible surface area of ∼6,000 Å^2^ for each subunit. There appears to be a certain degree of freedom around the dimerization arm, producing two distinct populations of dimers in the asymmetric unit. The first population consists of the chain pairs AB and IJ, which superpose with a root-mean-square deviation (RMSD) of 1.55 Å for 2,139 atoms, and the second population consists of chain pairs EF, KL, and GH, which all superpose with an RMSD of less than 0.8 Å for ∼2,000 atoms. When chain pairs from the two populations are superposed, the RMSD increases to ∼2.4 Å. Chain pair CD sits in a conformation between the two populations, superposing to AB and EF with RMSDs of 2.3 and 1.48 Å, respectively, highlighting the flexibility of the dimerization arm.

The main source of divergence between these two populations arises due to differences in rotation between the two Ub bodies in the dimer subunits. To compare the compactness of the dimer populations, we measured the distance between Leu69 in both subunits, which sits near the dimer interface, and found that both populations of dimer subunits are separated by a distance of about 20 Å for AB, 21 Å for CD, and 22 Å for EF ([Figure 3](#fig3){ref-type="fig"}A). Furthermore, we measured the angle formed between Asp39, Val10, and Asp39′ to describe the rotation between the two molecules ([Figure S1](#mmc1){ref-type="supplementary-material"}D). The populations differ quite dramatically, with angles of 144° for AB, 159° for CD, and 163° for EF. While these differences are obvious in the crystal lattice, theoretical scattering profiles calculated for each dimer configuration show no detectable differences between the two forms in solution. When compared with the published UbV.XR dimer structure, differences in rotation between the two Ub bodies are evident ([Figure 3](#fig3){ref-type="fig"}B), highlighting the flexibility in UbV dimer.Figure 3Dimerization Criteria(A) Superposed Cα-ribbon traces of chain AB (magenta) and chain EF (cyan) dimers from the two populations in the asymmetric unit of the crystal structure of Ub74 G10V, in wall-eye stereo. Leu69 from each subunit is shown as sticks and the dotted line shows the distance measured. See also [Figure S1](#mmc1){ref-type="supplementary-material"}D.(B) Superposed Cα-ribbon traces of UbV.XR alone (green, PDB: [5O6S](pdb:5O6S){#intref0165}) and Ub74 G10V (cyan). Leu69 from each subunit is shown as sticks.(C) Normalized analytical size-exclusion chromatogram of Ub74 G10V and Ub74 compared with variants in which other residues in the β1β2 loop have been individually replaced with Gly. See also [Figures S1](#mmc1){ref-type="supplementary-material"}E and S1F.(D) Normalized analytical size-exclusion chromatogram of NEDD8-Ubl, NEDD8-Ubl G10V, SUMO2-Ubl, and SUMO2-Ubl G24A G27V. There is no evidence of dimer formation in any of these Ubl variants.(E) As in (A) but including the K48-linked diUb from PDB: [5MN9](pdb:5MN9){#intref0170}, colored gray.

The β1β2 Loop Is Important for the Stability of Ub {#sec2.4}
--------------------------------------------------

Because substitution of G10 to Val changes the oligomeric state of Ub from a monomer to a dimer, we set out to determine whether the monomer could be recovered if a glycine was introduced elsewhere in the β1β2 loop ([Figure 1](#fig1){ref-type="fig"}B). Initially, residues Leu8 and Thr12 were substituted with glycine in Ub74 G10V, and analyzed by analytical size-exclusion chromatography as described above. Ub74 L8G G10V was monomeric, whereas Ub74 G10V T12G was dimeric ([Figure 3](#fig3){ref-type="fig"}C). To expand on the borders of where the glycine substitution can occur and still recover the monomeric state, we made a range of individual substitutions with glycine in Ub74 G10V, namely Phe4, Val5, Lys6, Thr7, Lys11, Ile13, Thr14, or Leu15. Ub74 G10V with V5G or T7G substitutions did not express soluble protein. When Phe4 or Lys6 was substituted with glycine in Ub74 G10V, the protein remained a dimer ([Figure S1](#mmc1){ref-type="supplementary-material"}E). While a Lys11 substitution with Gly was monomeric, when Ile13, Thr14, or Leu15 was substituted with Gly in Ub74 G10V, the protein was predominantly a dimer ([Figure S1](#mmc1){ref-type="supplementary-material"}F). Based on these gel-filtration profiles, our data suggest that a Gly substitution within the β1β2 loop of Ub74 G10V is sufficient to maintain the monomeric state of Ub; however, a Gly substitution in neighboring residues in β1 or β2 does not affect dimer formation caused by substitutions in Gly10.

Dimerization via a Single Mutation Is Unique to Ub {#sec2.5}
--------------------------------------------------

Structure-based sequence alignments with a number of ubiquitin-like proteins (Ubls) revealed that several contained Gly residues in positions corresponding to Gly10 in Ub. We introduced Val substitutions at these positions in two Ubls derived from NEDD8 and SUMO2, and investigated their oligomeric state by size-exclusion chromatography ([Figure 3](#fig3){ref-type="fig"}D). No dimer formation was apparent in either Val-substituted Ubl although there was a marked reduction in solubility of the NEDD8-Ubl variant. Because the SUMO2-Ubl contains a second Gly in the loop between β1 and β2 that might potentially compensate for any inflexibility introduced as observed in Ub, we also analyzed the SUMO2-Ubl G24A G27V double mutant using gel-filtration chromatography and found no evidence of oligomerization ([Figure 3](#fig3){ref-type="fig"}D). These data suggest that other surrounding residues contribute to the stability of Ubl folds, and that further mapping of these regions is required to ascertain how these residues contribute to dimer formation and stability.

Discussion {#sec3}
==========

Ub scaffold libraries have been used to develop affinity reagents for a broad range of applications including probing cell signaling networks, elucidating protein function, and delivering targeted biotherapeutics ([@bib3], [@bib11], [@bib13], [@bib15], [@bib22], [@bib23], [@bib34], [@bib32], [@bib33]). Generating new search spaces relies on increasing the diversity of the Ub scaffold libraries. In a previous study, we serendipitously identified UbV.XR, which self-associates to form a stable non-covalent dimer and only binds its target as a dimer. In UbV.XR, Ala10 in the β1β2 loop is essential for dimerization but whether there are contributions from other mutations in this region is unknown. To facilitate the use of this non-covalent dimer conformation as a scaffold to generate additional UbV libraries, we investigated substitution requirements in the β1β2 loop of Ub to convert it to a dimer. We found that a single substitution of Gly10 with Ala or Val is sufficient to induce dimerization of Ub and that Ub74 G10V reverts to a monomeric state when certain other residues from the β1β2 loop are substituted with Gly. A crystal structure of Ub74 G10V shows that the dimer interface resembles that of UbV.XR, and SAXS analyses suggest this dimer conformation is also present in solution. Substitution of Gly to Val in the β1β2 loop of NEDD8-Ubl or SUMO2-Ubl does not promote dimerization, demonstrating that this mechanism for dimer formation is specific to Ub.

Of the Gly10 substitutions tested (Ala, Val, Leu, Met, Phe, or Arg), only Val and Ala promoted dimer formation. Interestingly, the monomeric populations of each of these variants had lower melting point temperatures than either wild-type Ub or the other UbVs. This mutation-induced instability might be a factor that allows β1 to detach from the β sheet in the globular body of the monomer to form the dimer. Once formed, the dimer appears to be very stable, as there was no evidence of dissociation to a monomer. However, Ub74 G10V reverted to monomer when other residues in the β1β2 loop were substituted with glycine, suggesting that the presence of a Gly in this loop plays a critical role in Ub\'s ability to form a non-covalent domain-swapped dimer. Nevertheless, our data show that this non-covalent dimerization is only observed in Ub and not other Ubls despite their high structural conservation; hence, it is likely that other factors also play a role in dimerization.

What drives dimer formation is as yet unclear. Despite ubiquitin being a compact globular protein, it has several flexible regions including the C-terminal tail that is essential for conjugation and the β1β2 loop ([@bib12]). We hypothesize that two steps occur in the formation of Ub74 G10A or G10V dimers: these Gly10 mutations promote instability, allowing β1 to detach from β2, and, while the strand is dislodged, it interacts with a similarly β1-detached neighboring molecule to form a dimer. Another dimeric UbV selective for the deubiquitinase USP15 exhibits the same strand exchange as observed in Ub74 G10V ([@bib26]); although there is no substitution of Gly10, a loop insertion is present between residues Leu8 and Thr9 that may account for the required destabilization. Whether there are other factors that contribute to dimer formation or whether there is a threshold for stability is unclear. The melting temperature of Ub74 G10F is higher than that of Ub74 G10V or G10A but lower than that of Ub74, and in cases such as this, two free β1-strand molecules may not encounter one another so it is energetically more favorable to return to a native state.

There are a number of diUb structures available in the PDB that are formed from linkages involving Lys side chains or linear Met1 chains. The overall shape of the Ub74 G10V dimer and the various diUbs appear similar when superposed, as they comprise two globular proteins connected by a short linker consisting of the C-terminal tail and a lysine side chain, or by the elongated β1 observed in Ub74 G10V. However, superposition of one Ub chain from each structure reveals that the two Ub chains relate to each other through a wide range of angles. The closest structural arrangement to Ub74 G10V is the open conformation of K48-linked diUb from 5MN9 in which the diUb is part of a complex with a fragment of the DUB MINDY-1/FAM63A. In both Ub74 G10V and this K48-linked diUb, the distance between Leu69 and Leu69′ is 22 Å ([Figure 3](#fig3){ref-type="fig"}E).

Based on rotational conformational differences between the two Ub bodies of dimeric subunits within the asymmetric unit, our Ub74 G10V dimer structure suggests that the dimerization arm is flexible. This feature was not observed in our prior UbV.XR structure, but when UbV.XR is bound to XR it becomes more compact and the distance between the Leu69 in each UbV.XR decreases from 20 to 15 Å ([@bib11]). Interactions with XR appear to stabilize the dimerization arm in UbV.XR and increase the dimer compactness, suggesting that the Ub dimer may also become more compact upon binding to another protein.

The discovery of dimeric UbV.XR and its stimulatory effect upon its target, XIAP RING, suggests there is scope to expand upon the diversity covered by current phage-displayed UbV libraries. In this study, we set out to elucidate which Ub residues require substitution to form a dimeric scaffold and found that substitution of Gly10 to Val or Ala was sufficient, provided no other Gly substitutions are introduced in the β1β2 loop. These substitutions can be used to develop next-generation libraries that will encode dimeric UbVs with novel interfaces for protein recognition. There is increased interest in developing dimeric UbVs, as these may allow improved specificity and binding and exploit bivalent avidity effects. Recently, [@bib26] developed linear dimeric UbVs selective for the deubiquitinase USP15 by linking together UbVs that bind tandem domains of this enzyme. These dimeric UbVs show an increased binding to and inhibition of the deubiquitinase USP15 compared with other deubiquitinases. Should a dimeric UbV library be available for screening, we anticipate that this approach may be useful for a number of applications, particularly for elucidating and manipulating the activity of hetero- and homodimeric RING E3s.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Bacterial and Virus Strains***Escherichia coli* BL21(λDE3) GOLDLaboratory stockN/A**Chemicals, Peptides, and Recombinant Proteins**2-mercaptoethanol 99% 14.3 M (BME)Sigma-AldrichCat\#M3148Dithiothreitol (DTT)FormediumCat\#DTT025Glutathione, reduced, free acidFisher Scientific UKCat\#11483074Imidazole BioUltraSigma-AldrichCat\#56749Isopropyl-β-D-1-thiogalactoside (IPTG)FormediumCat\#IPTG025Phenylmethanesulfonyl fluoride (PMSF)Sigma-AldrichCat\#P7626Ub74 and variants([@bib11]) This paperN/ASUMO2-91 and variantsThis paperN/ANEDD8-74 and variantsThis paperN/A**Critical Commercial Assays**Morpheus screenMolecular DimensionsCat\#MD1-46**Deposited Data**Ub74 G10VThis paperPDB: [6QK9](pdb:6QK9){#intref0010}UbV.XR from BIRC4 (XIAP) RING in complex with dimeric ubiquitin variant([@bib11])PDB: [5O6T](pdb:5O6T){#intref0015}UbV.XR / UbV.B4R a dimeric ubiquitin variant binding to BIRC4 (XIAP) RING([@bib11])PDB: [5O6S](pdb:5O6S){#intref0020}Ub([@bib29])PDB: [1UBQ](pdb:1UBQ){#intref0025}K48-diUb from MINDY-1 tMIU in complex with K48-diUb([@bib19])PDB: [5MN9](pdb:5MN9){#intref0030}Chain B of Met1-diUb from OTULIN OTU domain (C129A) in complex with Met1-di ubiquitin([@bib17])PDB: [3ZNZ](pdb:3ZNZ){#intref0035}SAXS dataThis paper<https://doi.org/10.17632/wbbjg5kwr8.1>**Recombinant DNA**pGEX4T1 HG TEV Ub74([@bib11])N/ApGEX4T1 HG TEV Ub74 G10VThis paperN/ApGEX4T1 HG TEV Ub74 G10AThis paperN/ApGEX4T1 HG TEV Ub74 G10LThis paperN/ApGEX4T1 HG TEV Ub74 G10MThis paperN/ApGEX4T1 HG TEV Ub74 G10FThis paperN/ApGEX4T1 HG TEV Ub74 G10WThis paperN/ApGEX4T1 HG TEV Ub74 T7G G10VThis paperN/ApGEX4T1 HG TEV Ub74 K6G G10VThis paperN/ApGEX4T1 HG TEV Ub74 V5G G10VThis paperN/ApGEX4T1 HG TEV Ub74 F4G G10VThis paperN/ApGEX4T1 HG TEV Ub74 G10V K11GThis paperN/ApGEX4T1 HG TEV Ub74 G10V T12GThis paperN/ApGEX4T1 HG TEV Ub74 G10V I13GThis paperN/ApGEX4T1 HG TEV Ub74 G10V T14GThis paperN/ApGEX4T1 HG TEV Ub74 G10V L15GThis paperN/ApGEX4T1 HG TEV Ub74 G10V E16GThis paperN/ApGEX4T1 HG TEV NEDD8 74This paperN/ApGEX4T1 HG TEV NEDD8 74 G10VThis paperN/ApGEX4T1 HG TEV SUMO2 91This paperN/ApGEX4T1 HG TEV SUMO2 91 G27VThis paperN/ApGEX4T1 HG TEV SUMO2 91 G24A G27VThis paperN/A**Software and Algorithms**GraphPad Prism version 7GraphPad Software<http://www.graphpad.com>; RRID: [SCR_002798](rridsoftware:SCR_002798){#interref180}xia2 pipeline([@bib31])<http://xia2.github.io>; RRID: [SCR_015746](rridsoftware:SCR_015746){#interref200}XDS([@bib16])<http://xds.mpimf-heidelberg.mpg.de/>; RRID: [SCR_015652](rridsoftware:SCR_015652){#interref205}AIMLESS([@bib10])<http://www.ccp4.ac.uk>; RRID: [SCR_015747](rridsoftware:SCR_015747){#interref210}MoRDA([@bib28])<https://ccp4serv7.rc-harwell.ac.uk/ccp4online/>; RRID: [SCR_007255](rridsoftware:SCR_007255){#interref280}PHENIX([@bib1])<https://www.phenix-online.org/>; RRID: [SCR_014224](rridsoftware:SCR_014224){#interref285}COOT([@bib8])<https://www2.mrc-lmb.cam.ac.uk/personal/pemsley/coot/>; RRID: [SCR_014222](rridsoftware:SCR_014222){#interref290}MOLPROBITY([@bib5])<http://molprobity.biochem.duke.edu/>; RRID: [SCR_014226](rridsoftware:SCR_014226){#interref295}ALINE([@bib2])<http://bondxray.org/software/aline.html>; RRID: [SCR_016886](rridsoftware:SCR_016886){#interref300}PyMOLThe PyMOL Molecular Graphics System, v. 1.8.4.0, Schrodinger, LLC<http://www.pymol.org>; RRID: [SCR_000305](rridsoftware:SCR_000305){#interref305}SCÅTTERSCÅTTER Version 3.1r<http://www.bioisis.net>; RRID: [SCR_017271](rridsoftware:SCR_017271){#interref310}FoXS([@bib35])<https://modbase.compbio.ucsf.edu/foxs/>; RRID: [SCR_017269](rridsoftware:SCR_017269){#interref315}DAMAVER([@bib30])<https://www.embl-hamburg.de/biosaxs/damaver.html>; RRID: [SCR_015648](rridsoftware:SCR_015648){#interref320}SASRES([@bib27])<https://www.embl-hamburg.de/biosaxs/software.html>; RRID: [SCR_015648](rridsoftware:SCR_015648){#interref325}DAMFILT([@bib30])<https://www.embl-hamburg.de/biosaxs/damaver.html>; RRID: [SCR_015648](rridsoftware:SCR_015648){#interref330}GASBOR([@bib25])<https://www.embl-hamburg.de/biosaxs/gasbor.html>; RRID: [SCR_015648](rridsoftware:SCR_015648){#interref335}**Other**Glutathione agarose resinWeb ScientificCat\#ABT 4B-GLU-100Ni^2+^ agarose resinWeb ScientifcCat\#ABT 6BCL-QHNi-100SD75 26/60 size-exclusion chromatography columnGE HealthcareCat\#28-9898-34SD75 10/300 analytical size-exclusion chromatography columnGE HealthcareCat\#17-5175-01Protein Thermal Shift KitApplied Biosystems, Thermo Fisher ScientificCat\#44611467500 FAST RT-PCR machineApplied Biosystems, Thermo Fisher ScientificN/A

Lead Contact and Materials Availability {#sec4.2}
---------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Danny T. Huang (<d.huang@beatson.gla.ac.uk>).

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### Recombinant Proteins {#sec4.3.1}

Recombinant proteins were overexpressed in *Escherichia coli* BL21(λDE3) GOLD cells. Cultures were grown at 37°C in Luria Bertani media until an OD~600~ of 0.6--0.8 was reached, followed by induction with 0.2 mM isopropyl β-D-1-thiogalactopyranoside and incubation at 18--20°C overnight.

Method Details {#sec4.4}
--------------

### Generation of New Constructs {#sec4.4.1}

β1-β2 loop variants of Ub and Ubls were generated using standard PCR-ligation techniques and verified by automated sequencing. All UbVs and Ubls were cloned into pEX4T1 (GE Healthcare) modified with a TEV cleavage site and an N-terminal His-tag (pGEX4T1 HG TEV) and include DNA encoding the sequence GGS at the N-terminus prior to Met1 but lacking the C-terminal diglycine.

### Protein Purification {#sec4.4.2}

After expression, cell cultures were harvested by low-speed centrifugation, resuspended in 50mM Tris-HCl pH 7.6, 200 mM NaCl, 2.5 mM phenylmethanesulfonyl fluoride (PMSF) and 15 mg lysozyme per liter culture, before being flash frozen in liquid nitrogen. The pellets were thawed and sonicated. Lysates were cleared by centrifugation at 50,000 *g* and then loaded onto glutathione agarose resin, followed by incubation for 1-2 hours. The proteins were washed in 50 mM Tris-HCl pH 7.6, 200 mM NaCl, 5 mM β-mercaptoethanol (BME), and eluted in 25 mM Tris-HCl pH 7,6, 150 mM NaCl, 5 mM BME, 10 mM glutathione. TEV protease was used to cleave the affinity tags, which were removed by further Ni^2+^-affinity chromatography. The proteins were concentrated to 5 ml, and applied onto a 26/60 SD75 gel filtration column, pre-equilibrated in 25 mM Tris-HCl pH 7.6, 150 mM NaCl, 1 mM DTT. All purification steps were carried out at 4°C.

### Analytical Gel Filtration {#sec4.4.3}

Ub74 and variants were applied onto a Superdex 75 10/300 column pre-equilibrated in 25 mM Tris-HCl, pH 7.6, 150 mM NaCl, 1 mM DTT at constant flow-rate at 4°C.

### Differential Scanning Fluorimetry (DSF) Assays {#sec4.4.4}

Proteins were mixed with buffer and ROX dye using the Protein Thermal Shift Dye Kit and thermal scanning (25 to 95°C at 1°C per minute) was performed using an Applied Biosystems 7500 FAST RT-PCR machine. Assay reactions were set up in triplicate in a 96-well PCR plate. Curve fitting and melting temperature calculations were performed using the basic Boltzmann sigmoid function in GraphPad Prism (version 7).

### Small-Angle X-Ray Scattering (SAXS) Data Collection and Analyses {#sec4.4.5}

Protein was brought to Diamond Light Source station B21 for bioSAXS. Data were collected on a range of protein concentrations for both Ub74 G10V (from 50 mg/ml to 3.1 mg/ml) and Ub74 (from 25 mg/ml to 3.1 mg/ml). The protein samples were kept chilled until injected into the x-ray beam. Data were processed and the distance distribution function and maximum distance (D~max~) were calculated using SCÅTTER version 3.1r (<http://www.bioisis.net>).

Theoretical scattering curves were calculated and fitted against available crystal structures using FoXS ([@bib35]). Twenty a*b initio* models were calculated by GASBOR ([@bib25]) and average models of these were calculated using DAMAVER and DAMFILT ([@bib30]). The resolution of the space-filled models was calculated using SASRES ([@bib27]).

### Crystallization {#sec4.4.6}

Ub74 G10V was concentrated to approximately 50 mg/ml, and mixed in a 1:1 ratio of reservoir. Long rods, appearing within 24 hours, were grown using sitting drop vapour diffusion in 96 well trays. Initial crystals hits occurred in Morpheus HT-96 screen, condition 1. Final crystals were grown using hanging drop vapour diffusion in 24 well trays, where protein was mixed with the reservoir at 2:1 ratio. Furthermore, Buffer System 1 from the original condition was substituted with 1M MES pH 6.5.

### Structure Determination and Refinement {#sec4.4.7}

Crystals were frozen without additional cryo-protection and brought to Diamond Light Source station I04-1. Data were collected in 0.2° slices, and processed by the XIA2 pipeline, relying on XDS ([@bib16]) and AIMLESS ([@bib10]). The structure was determined by molecular replacement using the MoRDA server ([@bib28]), which utilized a library of structures of ubiquitin from the PDB, finally determining the structure using chain B from PDB ID [3ZNZ](pdb:3ZNZ){#intref0135}. Refinement was done in PHENIX ([@bib1]), with inspection of the maps and manipulation of the model in COOT ([@bib8]). Waters were added in COOT. Polder density maps were calculated in PHENIX and used to confirm the model.

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

[Table 1](#tbl1){ref-type="table"} and [Figure 2](#fig2){ref-type="fig"} contain quantitative parameters related to data and refinement statistics for X-ray crystallography and SAXS experiments. Melting temperatures related to [Figure 1](#fig1){ref-type="fig"}E were obtained from the inflection point of melting curves measured in triplicate and fitted with the basic Boltzmann sigmoid function in GraphPad Prism (version 7). Normalization of absorbance on gel filtration chromatograms ([Figures 1](#fig1){ref-type="fig"}, [3](#fig3){ref-type="fig"}, and [S1](#mmc1){ref-type="supplementary-material"}) was performed using the following equation:$$\ A_{norm}\  = \frac{\left( {A - A_{min}} \right)}{\left( {A_{max} - A_{min}} \right)}$$

Data and Code Availability {#sec4.6}
--------------------------

The accession number for atomic coordinates and structure factors for the X-ray crystal structures of Ub74 G10V is PDB: [6QK9](pdb:6QK9){#intref0140}. SAXS data are available in the Mendeley Data Repository (<https://doi.org/10.17632/wbbjg5kwr8.1>). Other data generated in this study are available from the Lead Contact upon request.

Supplemental Information {#app2}
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